Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial

Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:28:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    An NIH announcement says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:26:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:29:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link, leaving the trial details unavailable.
    Difference
    0.5%
    Check dated 2026-10-03T22:11:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed, replacing the study details and navigation. Viewers can no longer access the study record from this page.
    Difference
    17%
    Check dated 2026-09-19T20:53:18.000Z thumbnail image

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.